Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase II associated protein 2 (RPAP2) is a protein phosphatase and transcription regulatory factor that binds to and regulates RNA polymerase II, the central enzyme responsible for mRNA synthesis in eukaryotes[1][2][4][7]. RPAP2 primarily functions by dephosphorylating serine residues (notably Ser-5) in the C-terminal domain (CTD) of Pol II, thus promoting or fine-tuning transcription initiation and elongation, especially of small nuclear RNA (snRNA) genes[2][7]. It recognizes phosphorylated Ser-7 of the CTD, influencing both transcriptional activity and RNA processing[2]. Structurally, RPAP2 binds between the jaw domains of the Pol II subunits RPB1 and RPB5, and is involved in nuclear import of RNA polymerase II[1]. RPAP2 is displaced from Pol II during the formation of the transcription pre-initiation complex and upon DNA engagement, consistent with its role in regulating Pol II assembly and nuclear transport rather than ongoing transcription[1][3]. In addition to its role in transcription, RPAP2 participates in the unfolded protein response by dephosphorylating ER stress sensors, with implications for cell fate under ER stress conditions[2]. The yeast homolog of RPAP2, Rtr1, shares similar functions but varies in phosphatase activity depending on the species[1]. As of now, RPAP2 is not a recognized therapeutic target, and no drugs are known to act directly on it. There are no reports of RPAP2 serving as a clinically actionable biomarker or significant safety concerns associated with its manipulation[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase II associated protein 2 (RPAP2).